Study Title
ZERO2: Precision Medicine for Every Child With Cancer
Protocol ID
ZERO2
Disease (Sub Disease)
All paediatric cancer types
Diagnosis Stage
Newly diagnosed
Relapsed/Refractory
Relapsed/Refractory
Location
NSW, QLD, VIC, WA, SA, NZ, TAS
Sponsor
Australian & New Zealand Children's Haematology/Oncology Group
Collaborators
Sydney Children's Hospitals Network
Links
Trial Status
Open
Sites
The Children's Hospital at Westmead
Sydney Children's Hospital
Queensland Children's Hospital
Women's & Children's Hospital
John Hunter Children's Hospital
Royal Hobart Hospital
Monash Children's Hospital
The Royal Children's Hospital
Perth Children's Hospital
Starship Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
Women's & Children's Hospital
John Hunter Children's Hospital
Royal Hobart Hospital
Monash Children's Hospital
The Royal Children's Hospital
Perth Children's Hospital
Starship Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
0 Years to 25 Years
International registry ID's
NCT05504772
| Study Title | ZERO2: Precision Medicine for Every Child With Cancer |
|---|---|
| Protocol ID | ZERO2 |
| Disease (Sub Disease) | All paediatric cancer types |
| Diagnosis Stage | Newly diagnosed Relapsed/Refractory |
| Location | NSW / QLD / VIC / WA / SA / NZ / TAS |
| Sponsor | Australian & New Zealand Children's Haematology/Oncology Group |
| Collaborators | Sydney Children's Hospitals Network |
| Links | https://clinicaltrials.gov/ct2/show/NCT05504772 |
| Trial Status | Open |
| Trial Open Date | 16/12/2022 |
| Sites | The Children's Hospital at Westmead / Sydney Children's Hospital / Queensland Children's Hospital / Women's & Children's Hospital / John Hunter Children's Hospital/ Royal Hobart Hospital/ Monash Children's Hospital/ The Royal Children's Hospital/ Perth Children's Hospital/ Starship Children's Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | 0 Years to 25 Years |
| International registry ID's | NCT05504772 |